Himelstein, A. L., Foster, J. C., Khatcheressian, J. L., Roberts, J. D., Seisler, D. K., Novotny, P. J., Qin, R., Go, R. S., Grubbs, S. S., O'Connor, T., Velasco, M. R., Jr., Weckstein, D., O'Mara, A., Loprinzi, C. L., Shapiro, C. L. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA 2017; 1: 48-58

PubMed ID: PM:28030702